EUVIMEDEUVIMED entdecken
Crossref

L26/P-215 A treatment algorithm to address gamete-specific oocyte activation deficiency

A. Kim, P. Xie, S. Cheung, L. Ng, Z. Rosenwaks, G.D. Palermo

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Kim und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can a targeted treatment algorithm that addresses gamete-specific deficiencies better correct fertilization failure with intracytoplasmic sperm injection (ICSI)? Summary answer Gamete-specific assisted oocyte activation (AOA) based on sperm phospholipase C-zeta (PLCζ) screening can overcome oocyte- and/or sperm-related ICSI fertilization failure. What is known already Fertilization in conventional IVF may fail in couples with a compromised male gamete, Although the use of ICSI can overcome this, fertilization failure still occurs in up to 3% of cycles. This failure is commonly attributed to sperm defects at spermiogenesis, with an inability to properly activate oocytes. A popular treatment for fertilization failure is AOA, commonly performed with calcium ionophore; however, AOA cannot distinguish between the specific gamete contribution to the poor outcome. We propose a sperm PLCζ-dependent algorithm to identify the sperm- or oocyte-related contribution to fertilization failure. Study design, size, duration A pilot topographic analysis of PLCζ content in ejaculated, epididymal, and testicular spermatozoa was performed. During a span of 5 years, 135 consenting couples with poor ICSI fertilization (<20% 2PN) were screened for sperm PLCζ content (with a ≥ 30% normal threshold) and corroborated by gene studies by next-generation sequencing (NGS). When the PLCζ was below the threshold, the fertilization deficiency was considered sperm-related, whereas a normal PLCζ level indicated an oocyte-related fertilization failure. Participants/materials, setting, methods Couples with oocyte-related fertilization failure were treated by calcium ionophore. Couples with sperm-related fertilization failure due to a low activating protein content were treated by injection of rhPLCζ during ICSI. Couples with suspected concurrent gamete deficiencies were treated with dual-AOA combining rhPLCζ injection with concurrent exposure to calcium ionophore. Embryological and clinical outcome of the study cycles were compared to the patients’ own historical index cycle. Main results and the role of chance In the pilot study, the sperm PLCζ level in the ejaculate was 89.4±5%, decreasing in the epididymis (61.6±9%,P<0.01) and the testis (47.9±13%,P<0.001). The study population (maternal age 36.3±5 years, paternal age 36.9±5 years) had the following semen parameters: 2.4±2mL volume, 42.7±40 × 106/mL concentration, 33.9±21% motility, and 2.6±2% normal morphology. In patients with oocyte-related fertilization failure (n = 77,PLCζ level:68.2±17%), historical cycles yielded suboptimal fertilization (17.3%) and no pregnancy. Ionophore-AOA significantly improved fertilization (52.5%,P<0.0001), leading to a 54.8% pregnancy rate (P<0.001). In couples with a diminished PLCζ level of 5.8±3%(n = 20), sperm-related fertilization deficiency was corroborated by NGS, revealing pathogenic variants in genes involved in calcium signaling and fertilization, including PLCZ1. The historical cycle yielded an 18.3% fertilization rate and failed to generate a pregnancy; rhPLCζ-AOA rescued fertilization (41.4%,P<0.0001) and pregnancies (29.4%,P<0.05). In couples with unexplained/combined fertilization failure (n = 38,PLCζ level:32.6±14%), the historical cycle resulted in poor fertilization rate at 14.1% with no pregnancy. Dual-AOA demonstrated significant improvement in fertilization (73.2%,P<0.0001) and pregnancy (63.3%,P<0.0001) rates. In a sub-population (n = 11) utilizing testicular spermatozoa, with known diminished fertilization competence, historical cycles yielded a 17.1% fertilization fate and no pregnancy. When a dual-AOA was applied, fertilization was normalized at 74.8%(P<0.0001) as well as the pregnancy(63.6%). Limitations, reasons for caution This study has a small sample size due to the low overall prevalence of total/low fertilization failure with ICSI. The use of recombinant PLCζ requires further safety assessment, particularly on the health of the offspring. Wider implications of the findings PLCζ assessment identified fertilization competence of the male gamete according to maturity and the topographic source of the male genital tract. Moreover, it shows a promise as a guide toward a tailored, gamete-specific treatment for failed ICSI fertilization, that does not require the indiscriminate use of a calcium-release agent. Trial registration number No

Zitieren

APA

Kim, A., Xie, P., Cheung, S., Ng, L., Rosenwaks, Z., & Palermo, G. (2026). L26/P-215 A treatment algorithm to address gamete-specific oocyte activation deficiency. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.551

Vancouver

Kim A, Xie P, Cheung S, Ng L, Rosenwaks Z, Palermo G. L26/P-215 A treatment algorithm to address gamete-specific oocyte activation deficiency. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.551

BibTeX
@article{Kim2026,
  author = {Kim, A. and Xie, P. and Cheung, S. and Ng, L. and Rosenwaks, Z. and Palermo, G.D.},
  title = {L26/P-215 A treatment algorithm to address gamete-specific oocyte activation deficiency},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.551}
}
Kostenlos starten →